ACE and hydrops fetalis: As detailed in Section 2.3, 92.1% (375/407) of enrolled patients received standardized anti-HF treatment, defined as a combination of diuretics plus angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB), with a subset additionally receiving β-blockers.